Cerebrotendinous Xanthomatosis (CTX) Prevalence Study
Public ClinicalTrials.gov record NCT02638220. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Observational, Multicenter Study of the Prevalence of Cerebrotendinous Xanthomatosis (CTX) in Patient Populations Diagnosed With Early-Onset Idiopathic Bilateral Cataracts
Study identification
- NCT ID
- NCT02638220
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Travere Therapeutics, Inc.
- Industry
- Enrollment
- 442 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 2 Years to 21 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2015
- Primary completion
- Feb 18, 2021
- Completion
- Feb 18, 2021
- Last update posted
- Sep 18, 2024
2015 – 2021
United States locations
- U.S. sites
- 44
- U.S. states
- 28
- U.S. cities
- 41
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Travere Investigational Site | Birmingham | Alabama | 35294 | — |
| Travere Investigational Site | La Jolla | California | 92093 | — |
| Travere Investigational Site | Los Angeles | California | 90027 | — |
| Travere Investigational Site | Los Angeles | California | 90095 | — |
| Travere Investigational Site | Palo Alto | California | 94303 | — |
| Travere Investigational Site | Aurora | Colorado | 80045 | — |
| Travere Investigational Site | Gainesville | Florida | 32608 | — |
| Travere Investigational Site | Jacksonville | Florida | 32207 | — |
| Travere Investigational Site | Atlanta | Georgia | 30322 | — |
| Travere Investigational Site | Chicago | Illinois | 60611 | — |
| Travere Investigational Site | Indianapolis | Indiana | 46202 | — |
| Travere Investigational Site | Iowa City | Iowa | 52242 | — |
| Travere Investigational Site | Louisville | Kentucky | 40202 | — |
| Travere Investigational Site | New Orleans | Louisiana | 70121 | — |
| Travere Investigational Site | Baltimore | Maryland | 21201 | — |
| Travere Investigational Site | Boston | Massachusetts | 02115 | — |
| Travere Investigational Site | Ann Arbor | Michigan | 48105 | — |
| Travere Investigational Site | Detroit | Michigan | 48201 | — |
| Travere Investigational Site | Kansas City | Missouri | 64108 | — |
| Travere Investigational Site | St Louis | Missouri | 63103 | — |
| Travere Investigational Site | The Bronx | New York | 10467 | — |
| Travere Investigational Site | Chapel Hill | North Carolina | 27517 | — |
| Travere Investigational Site | Durham | North Carolina | 27708 | — |
| Travere Investigational Site | Cincinnati | Ohio | 45229 | — |
| Travere Investigational Site | Cleveland | Ohio | 44106 | — |
| Travere Investigational Site | Columbus | Ohio | 43205 | — |
| Travere Investigational Site | Oklahoma City | Oklahoma | 73104 | — |
| Travere Investigational Site | Portland | Oregon | 97239-3098 | — |
| Travere Investigational Site | Tigard | Oregon | 97223 | — |
| Travere Investigational Site | Philadelphia | Pennsylvania | 19104 | — |
| Travere Investigational Site | Philadelphia | Pennsylvania | 19107 | — |
| Travere Investigational Site | Charleston | South Carolina | 29425 | — |
| Travere Investigational Site | Germantown | Tennessee | 38103 | — |
| Travere Investigational Site | Nashville | Tennessee | 37232 | — |
| Travere Investigational Site | Houston | Texas | 77025 | — |
| Travere Investigational Site | Houston | Texas | 77030 | — |
| Travere Investigational Site | Salt Lake City | Utah | 84113 | — |
| Travere Investigational Site | Norfolk | Virginia | 23502 | — |
| Travere Investigational Site | Richmond | Virginia | 23298 | — |
| Travere Investigational Site | Seattle | Washington | 98105 | — |
| Travere Investigational Site | Spokane | Washington | 99204 | — |
| Travere Investigational Site | Tacoma | Washington | 98405 | — |
| Travere Investigational Site | Morgantown | West Virginia | 26506 | — |
| Travere Investigational Site | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02638220, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 18, 2024 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02638220 live on ClinicalTrials.gov.